{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-199246","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2022-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.603386+00:00","generated_at":"2026-06-24T10:03:01.592472+00:00","sec_items":["1.01","2.05","5.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Silverback Therapeutics to merge with ARS Pharmaceuticals; focus on needle-free epinephrine nasal spray neffy","bullets":["Silverback equity holders expected to own ~37%, ARS holders ~63% on fully-diluted basis.","Combined company expected to have ~$265M cash at close; merger expected Q4 2022; ticker to change to 'SPRY'.","Silverback to reduce workforce by ~73% by Sept 2, 2022; severance charges ~$13M cash + $2M non-cash.","ARS preparing NDA submission for neffy in Q3 2022; potential US launch in 2023.","Combined company CEO will be Rich Lowenthal (ARS); board of 10 members (7 from ARS, 3 from Silverback)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-199246","json":"https://secwatch.observer/filing/0001193125-22-199246.json","markdown":"https://secwatch.observer/filing/0001193125-22-199246.md","text":"https://secwatch.observer/filing/0001193125-22-199246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522199246/0001193125-22-199246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522199246/d379554d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T10:03:01.592472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}